货号 | CAS号 |
---|---|
M128010-5mg | 1072833-77-2 |
M128010-10mg | 1072833-77-2 |
M128010-100mg | 1072833-77-2 |
M128010-25mg | 1072833-77-2 |
M128010-50mg | 1072833-77-2 |
溶解性 |
|
存贮条件 | 储存温度-20°C |
产品介绍 | MLN2238(Ixazomib)能抑制20S蛋白酶体的糜蛋白酶样蛋白水解位点(β5),IC50和Ki分别为3.4 nM和0.93 nM。 |
生化机理 | MLN2238 inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with IC50 and Ki of 3.4 nM and 0.93 nM, respectively, also inhibits the caspase-like (β1) and trypsin-like (β2) proteolytic sites, with IC50 of 31 and 3500 nM. MLN2238 is a selective, potent, and reversible inhibitor of the proteasome in tumor cells. MLN2238 shows time-dependent reversible proteasome inhibition. |
别名 | MLN 2238;MLN-2238; B-[(1R)-1-[[2-[(2,5-二氯苯甲酰基)氨基]乙酰基]氨基]-3-甲基丁基]硼酸;Ixazomib;MLN 2238;MLN-2238; B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid |